Navigation Links
BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy
Date:12/4/2008

lity and length of stay and avoiding the increased costs associated with treating complications.

"CareFocus has been a tremendous asset to our organization and is a great example of how information technology is improving our delivery of care," said David House, vice president and chief information officer at BAPTIST HEALTH. "This solution places the powerful clinical information we have in our system into a single, easy-to-use format and allows our clinicians to be more responsive to patient needs. The idea was to identify at-risk patients faster, allowing our clinicians to intervene earlier, lower costs and improve outcomes. CareFocus enables us to do that."

BAPTIST HEALTH uses 100 CareFocus profiles across the system, broken out into 273 rounding lists. The pharmacy uses 37 of these profiles and has integrated them with Micromedex Healthcare Solutions drug reference information, another Thomson Reuters' offering, for a complete quality improvement solution.

Due to the initial success in the pharmacy, BAPTIST HEALTH has deployed the remaining profiles across several departments including infection control, case coordination, stroke center, nutrition and food services, nursing, and respiratory care.

"With CareFocus, our pharmacists are more efficient and have a more significant impact on patient care," said Tonya Robertson, Pharm.D., BCPS, pharmacy clinical coordinator for BAPTIST HEALTH Medical Center-Little Rock. "For example, we are using it to improve hospital vaccination rates, identify patients needing renal dose adjustments, and find opportunities to provide more cost-effective medications."

"CareFocus adds an extra safety net to guard our patients against adverse events from medications," adds Becky Layes, Pharm.D., pharmacist coordinator at BAPTIST HEALTH Rehabilitation Institute. "It places the information of our patients -- who might be at increased risk of havi
'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Sentillion and Baptist Health System to Speak at Upcoming Gartner Identity & Access Management Summit
2. Baptist Health System Deploys Sentillions Vergence Solution to Provide Secure Identity and Access Management to 3,000 Clinicians
3. Leading Neurologist Opens Missouri Baptist Medical Centers First MS Center
4. Alabamas Baptist Health System and Aegis Health Group Partner to Address Local Employers Health-Management Concerns
5. BlueCross Recognizes Baptist Womens Hospital
6. Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum
7. Valley Baptist Health System Leveraging TITAN Technology Partners Hosting and Managed Services
8. Baptist Memorial Health Care Donates More Than $3 Million to Tennessee Universities and Colleges
9. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
10. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
11. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4Welcome to the Biofuel Age of Flight 12593 1Welcome to the Biofuel Age of Flight 12593 2Welcome to the Biofuel Age of Flight 12593 3Students May Be Solution to Shortage of Medical Professionals 48719 1Students May Be Solution to Shortage of Medical Professionals 48719 2Students May Be Solution to Shortage of Medical Professionals 48719 3Students May Be Solution to Shortage of Medical Professionals 48719 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 1Hey Governator 21 Dont Terminate Senior Funding 21 48717 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 3Hey Governator 21 Dont Terminate Senior Funding 21 48717 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 5
Other Medicine Technology:Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 2Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 3Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 4Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 5Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 6Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 7Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 8BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 2BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 3BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 4BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 5BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 6BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 7